Cefdiren
Cheaper & Alternative Brands
Same generic (Cefditoren), same form (Tablet)Clinical Prescribing Information
Medical monograph and safety information for healthcare professionals & patients.Indications & Clinical Uses
Cefdiren is indicated for the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of the designated microorganisms in the conditions listed below:
Acute Bacterial Exacerbation of Chronic Bronchitis
Community Acquired Pneumonia
Pharyngitis
Tonsillitis
Uncomplicated Skin and Skin-Structure Infections
Dosage & Administration
Cefditoren should be taken after meals.
Community-Acquired Pneumonia
: 400 mg twice daily for 14 days.
Acute Exacerbation of Chronic Bronchitis
: 400 mg twice daily for 10 days.
Pharyngotonsillitis and Acute Sinusitis
: 200 mg twice daily for 10 days.
Uncomplicated Skin and Soft Structure Infections
: 200 mg twice daily for 10 days.
Contraindications
Cefditoren is contraindicated in patients with known allergy to the cephalosporin class of antibiotics or any of its components. Cefditoren contain sodium caseinate, a milk protein. Patients with milk protein hypersensitivity (not lactose intolerance) should not be administered Cefditoren.
Side Effects & Adverse Reactions
The most common side effects of Cefdiren are diarrhea, nausea, headache, abdominal pain, vaginal moniliasis, dyspepsia, vomiting, abnormal dreams, allergic reaction, anorexia, constipation, dizziness, dry mouth and fever.
Warnings & Precautions
Cefdiren is not recommended when prolonged antibiotic treatment is necessary, since other pivalate-containing compounds have caused clinical manifestations of carnitine deficiency when used over a period of months. Prescribing Cefdiren in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.
Pharmacology & Mechanism of Action
Cefditoren is a preparation of Cefditoren Pivoxil which is a broad spectrum third generation cephalosporin antibiotic. Cefditoren is a prodrug which is hydrolyzed by esterases during absorption, and the drug is distributed in the circulating blood as active Cefditoren. Cefditoren has antibacterial activity against gram-positive and gram-negative pathogens. The bactericidal activity of Cefditoren results from the inhibition of cell wall synthesis via affinity for penicillin- binding proteins (PBPs). Cefditoren is stable in the presence of a variety of ß-lactamases, including penicillinases and some cephalosporinases.